π½ Magnesium citrate + sodium picosulfate (e.g. Picolax/Citrafleet) is a bowel cleansing prep used before colonoscopy,
radiology, or surgery. β οΈ The main risks are dehydration and electrolyte disturbance (especially in frail/CKD/heart failure).
Encourage clear-fluid intake as directed and follow local endoscopy/radiology protocol.
About
- π Always check the BNF for product-specific instructions and safety advice.
- π§Ύ Used for bowel evacuation prior to endoscopy, radiological procedures (e.g. CT colonography), or surgery.
- β±οΈ Expect multiple watery stools; ensure patients plan access to a toilet and avoid travel immediately after dosing.
Mode of action
- π§² Magnesium citrate = osmotic effect β draws water into the bowel β softens stool and increases volume.
- β‘ Sodium picosulfate = stimulant laxative prodrug β activated by colonic bacteria β increases peristalsis and propulsion.
- π€ Together: flush + push β effective bowel cleansing when combined with adequate fluid intake.
Indication / Dose (typical regimen β follow local protocol)
- π§ͺ Bowel prep / colonoscopy: often 2 sachets total split dose.
- π₯€ Reconstitution: dissolve 1 sachet in 150 mL of cold water (about half a glass). Let it stop fizzing, then drink.
- π Split dose example: 1 sachet taken before 08:00, then 1 sachet 6β8 hours later (timing may vary with morning vs afternoon procedure).
- π§ Fluids: take plenty of clear fluids as instructed (this is crucial for effectiveness + safety).
- π« Usually avoid solids once the prep starts (follow the endoscopy unitβs dietary sheet).
Practical counselling points π‘
- π» Stay near a toilet after each dose; urgency is expected.
- π§» Consider barrier cream to prevent perianal soreness.
- π Do not drive long distances after dosing; plan transport for procedure day.
- π Ask about medication timing: diarrhoea can reduce absorption of oral meds β take essential meds earlier where possible and follow unit advice.
Interactions
- π See BNF for full list.
- π Reduced absorption of oral medicines (e.g. oral contraceptives, antiepileptics, immunosuppressants) due to rapid transit/diarrhoea β timing matters.
- π§ Drugs affecting electrolytes/volume (diuretics, ACEi/ARBs) may increase risk of dehydration, hypotension, and electrolyte derangement.
Cautions
- π§ Frailty, older age, low body weight β higher dehydration risk.
- π« Heart failure / significant cardiac disease (volume shifts can destabilise).
- π« Chronic kidney disease (risk of electrolyte disturbance).
- π§ Baseline dehydration or poor oral intake; consider alternative prep or supervised regimen.
- π§ͺ Abnormal electrolytes at baseline (especially sodium/potassium/magnesium) β correct and plan monitoring if high-risk.
Contraindications
- β Suspected/known bowel obstruction or ileus.
- π¨ Severe active colitis/toxic megacolon.
- π« Significant ascites (often specialist decision; many units choose alternative preps).
- π©Ί Any acute surgical abdomen / severe abdominal pain of unclear cause β do not give until assessed.
Side effects
- π Abdominal cramping, bloating, nausea, vomiting.
- π½ Profuse diarrhoea (expected), perianal soreness.
- π Dehydration, dizziness, postural symptoms.
- π§ Electrolyte disturbance (hyponatraemia, hypokalaemia Β± magnesium changes), especially if frail/CKD/diuretics.
References
Revisions